Abstract
In echocardiographic and necropsy studies nodular thickening of the mitral valve and, less frequently, of the aortic valve has been found in 60%–90% of patients with mucopolysaccharidoses (MPS). Little is known about the haemodynamic consequences of these morphological changes. In this study 84 unselected patients with different enzymatically proven MPS and 84 age and sex matched, healthy persons were studied prospectively by colour Doppler flow mapping. The patients' age ranged from 1 to 47 years (median 8.1 years). Mitral and aortic regurgitation were defined as a holosystolic or holodiastolic jet originating from the valve into the left atrium or the left ventricular outflow tract, respectively, with peak velocities exceeding 2.5 m/s. Of the 84 patients with satisfactory studies, mitral regurgitation was detected in 64.3% and aortic regurgitation in 40.5%, respectively. Regurgitation was severe in 4.8% of mitral valves and 8.3% of aortic valves. The frequency of aortic and/or mitral regurgitation was 75% in all patients, 89% in MPS I, 94% in MPS II, 66% in MPS III, 33% in MPS IV, and 100% in MPS VI. Combined mitral and aortic regurgitation was present in 29% of our patients. None of the control persons showed mitral or aortic regurgitation.
Similar content being viewed by others
Abbreviations
- MPS IH :
-
Hurler disease
- MPS IS :
-
Scheie disease
- MPS II :
-
Hunter disease
- MPS III :
-
Sanfilippo disease
- MPS IV :
-
Morquio disease
- MPS VI :
-
Lamy-Maroteaux disease
References
American Heart Association (1984) Committee report on prevention of bacterial endocarditis. Circulation 70: 123A-1127A
Berger M, Hecht SR, Van Tosh A, Lingam U (1989) Pulsed and continuous wave Doppler echocardiographic assessment of valvular regurgitation in normal subjects. J Am Coll Cardiol 13: 1540–1545
Brand A, Dollberg S, Keren A (1992) The prevalence of valvular regurgitation in children with structurally normal hearts: a color Doppler echocardiographic study. Am Heart J 123: 177–180
Ciobanu M, Abbasi AS, Allen M, Hermer A, Spellberg R (1982) Pulsed Doppler echocardiography in the diagnosis and estimation of severity of aortic insufficiency. Am J Cardiology 49: 339–343
Dangel J (1993) Evaluation of cardiovascular changes in children with the mucopolysaccharide storage disease. Abstract book: III Int Symposium on the Mucopolysaccharidosis (abstract)
Folger GM Jr, Hajar R, Robida A, Hajar HA (1992) Occurrence of valvar heart disease in acute rheumatic fever without evident carditis: colour-flow Doppler identification. Br Heart J 67: 434–438
Gal RA, Shalev Y, Schmidt DH (1990) Mitral regurgitation: parameters that affect the correlation between Doppler echocardiography and contrast ventriculography. Int J Cardiol 28: 87–93
Galassi AR, Nihoyannopoulos P, Pupita G, Odawara H, Crea F, McKenna WJ (1990) Assessment of colour flow imaging in the grading of valvular regurgitation. Eur Heart J 11: 1101–1108
Gross DM, Williams JC, Caprioli C, Dominguez B, Howell RR (1988) Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol 61: 170–176
Helmcke F, Nanda NC, Hsuing MC, Soto B, Adey CK, Goyal RG, Gatewood RP (1987) Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75: 175–183
John RM, Hunter D, Swanton RH (1990) Echocardiographic abnormalities in type IV mucopolysaccharidosis. Arch Dis Child 65: 746–749
Johnson GL, Vine DL, Cottrill CM, Noonan JA (1981) Echocardiographic mitral valve deformity in the mucopolysaccharidoses. Pediatrics 67: 401–406
Krovetz LJ, Lorincz AE, Schiebler GL (1965) Cardiovascular manifestations of the Hurler syndrome. Hemodynamic and angiocardiographic observations in 15 patients. Circulation 31: 132–141
Leroy JG, Wiesmann U (1993) Disorders of lysosomal enzymes. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders: molecular, genetic and medical aspects. Wiley-Liss Inc., New York, pp 613–639
Miyatake H, Izumi S, Okamoto M, Kinoshita N, Asonuma H, Nakagawa H, Yamamoto K, Takamia M, Sakakibara H, Nimura Y (1986) Semiquantitative grading of severity of mitral regurgitation by real-time, two-dimensional Doppler flow imaging technique. J Am Coll Cardiol 7: 82–88
Nelson J, Shields MD, Mulholland HC (1990) Cardiovascular studies in the mucopolysaccharidoses. J Med Genet 27: 94–100
Neufeld EF, Muenzer J (1989) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inheredited disease, 6th edn. McGraw-Hill, New York, pp 1565–1588
Perry GJ, Helmcke F, Nanda MC, Byard C, Soto B (1987) Evaluation of aortic insufficiency by Doppler flow mapping. J Am Coll Cardiol 9: 952–959
Renteria VG, Ferrans VJ, Roberts WC (1976) The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases. Am J Cardiol 38: 487–501
Schieken RM, Kerber RE, Ionasescu VV, Zellweger H (1975) Cardiac manifestations of the mucopolysaccharidoses. Circulation 52: 700–705
Simpson IA, Sahn DJ (1991) Quantification of valvular regurgitation by Doppler echocardiography. Circulation 84: I188-I192
Spranger J, Koch F, McKusik VA, Natzschka J, Wiedeman HR, Zellweger H (1970) Mucopolysaccharidosis VI (Maroteaux-Lamy's disease). Helv Paediatr Acta 25: 337–341
Tan CT, Schaff HV, Miller FA Jr, Edwards WD, Karnes PS (1992) Valvular heart disease in four patients with Maroteaux-Lamy syndrome. Circulation 85: 188–195
Wassman ER, Johnson K, Shapiro LJ, Itabashi H, Rimoin DL (1982) Postmortem findings in the Hurler-Scheie syndrome (mucopolysaccharidosis I-H/S). Birth Defects 18: 13–18
Weyman AE (1994) The abnormal mitral valve echocardiogram. In: Weyman AE (ed) Principles and practice of echocardiography, 2nd edn. Lea and Febiger, Philadelphia, pp429
Yoshida K, Yoshikawa J, Sakudo M, et al (1988) Color Doppler evaluation of valvular regurgitations in normal subjects. Circulation 78: 840–847
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wippermann, C.F., Beck, M., Schranz, D. et al. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr 154, 98–101 (1995). https://doi.org/10.1007/BF01991908
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01991908